PDCD1 and neoplasm: Similarly, inhibitors of programmed cell death protein 1 (PD-1) strengthen immune responses by preventing PD-1 from binding to its ligand, which normally suppresses tumor cell apoptosis and converts T effector cells into regulatory cells, impairing their cytotoxic function (1).